Transdermal drug delivery systems (TDDS) are medicated adhesive bandages or patches that are applied to the skin to transfer a drug dose via the skin and into the bloodstream. This patch facilitates faster healing of body wounds, offers a consistent infusion of the drug throughout time, and boosts the therapeutic effect of drugs by avoiding drug-related problems. This is a simple approach in which a patch is placed on the wounded portion of the body, from which the medicine slowly penetrates the skin and cures the injury.
The potential benefits of transdermal drug delivery systems are that they are non-invasive, less painful, give controlled plasma levels of strong drugs, can be stopped at any moment if needed, are a price effective therapy, and the bandages or patches is detachable. Adhesive, blacking, Liner, membrane, matrix filler, drug, and permeation enhancer are the major components of TDDS. TDDS can be a multi-layer drug in adhesive, single-layer drug in adhesive, matrix, reservoir, or vapor.
Request Here For FREE PDF Brochure With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/689
The advancements in the technology of transdermal drug delivery systems are expected to propel the global transdermal drug delivery market growth over the forecast period. Transdermal patch design improvement, the addition of pressure-sensitive adhesives, and permeation enhancers result in improved drug absorption and enhanced capacity to store the medication in excess amounts.
Transdermal drug delivery systems market taxonomy
Transdermal Drug Delivery Systems Market by Application:
- Neurological Disorders Pain Management
- Hormone Replacement Therapy
- Smoking Cessation
Transdermal Drug Delivery Systems Market by Technology:
- Electric current
- Radio Frequency
- Mechanical arrays
Transdermal Drug Delivery Systems Market by Geography:
- North America
- Latin America
- Asia Pacific
- Middle East
The increase in the number of surgeries performed around the world, as well as the incidence of cardiovascular diseases, is expected to fuel the global transdermal drug delivery system market growth over the forecast period.
Get FREE Sample Report With Latest Covid19 Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/689
Due to the increase in emergency medical situations and surgeries, North America and the Asia Pacific are expected to have massive growth in the transdermal drug delivery system market. According to the World Health Organization, the global surgical number was around 312.9 million in 2012. Cardiovascular diseases are expected to expand at an exponential rate over the forecast period, owing to the increased use of transdermal drug delivery systems. According to the American Heart Association, the number of heart attacks in the U.S. was expected to be around 58000 in 2014, and the global incidences of stroke were expected to be around 25.7 million in 2013. According to the World Health Organization, around 17.7 million people died in 2015 from cardiovascular diseases (CVDs), accounting for around 31 % of global deaths, with coronary heart disease accounting for around 7.4 % of these deaths.
The rise in various types of disorders, such as skin ulcers, acne, and skin rashes, results in an increase in surgeries, which can be related to a rise in the use of transdermal drug delivery systems. According to the World Health Organization, the global surgical volume in 2012 was around 312.9 million, with an estimated mean global surgical rate of 4469 operations for every 100 000 people each year.
Do You Have Specific Requirement? Ask To Our Experts: https://www.coherentmarketinsights.com/insight/talk-to-analyst/689
Major players in the global transdermal drug delivery systems market are:
Mylan Pharmaceuticals Inc., Teikoku Seiyaku Co., Ltd., Mylan N.V., Johnson & Johnson Limited, TEH SENG Pharmaceutical Mfg. Co., Ltd., GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Hisamitsu Pharmaceutical Co. Inc., Actelion Pharmaceuticals Ltd, Noven Pharmaceuticals Inc., ALLERGAN, Pfizer, Inc., Upsher-Smith Laboratories, Inc., Endo International plc, 3M Pharmaceuticals Inc., Actavis Inc., IBSA Institut Biochimque SA, BioGel Technology Inc., Janssen Pharmaceuticals, Inc., Bayer Crop Science Ltd., Therapeutics Inc., and Novartis AG.
Reasons to Purchase this Report
• Current and future of global Transdermal Drug Delivery Systems Market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/689
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Transdermal Drug Delivery Systems Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Transdermal Drug Delivery Systems Industry Impact
Chapter 2 Global Transdermal Drug Delivery Systems Competition by Types, Applications, and Top Regions and Countries
2.1 Global Transdermal Drug Delivery Systems (Volume and Value) by Type
2.3 Global Transdermal Drug Delivery Systems (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Transdermal Drug Delivery Systems Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Transdermal Drug Delivery Systems Market Analysis
Chapter 6 East Asia Transdermal Drug Delivery Systems Market Analysis
Chapter 7 Europe Transdermal Drug Delivery Systems Market Analysis
Chapter 8 South Asia Transdermal Drug Delivery Systems Market Analysis
Chapter 9 Southeast Asia Transdermal Drug Delivery Systems Market Analysis
Chapter 10 Middle East Transdermal Drug Delivery Systems Market Analysis
Chapter 11 Africa Transdermal Drug Delivery Systems Market Analysis
Chapter 12 Oceania Transdermal Drug Delivery Systems Market Analysis
Chapter 13 South America Transdermal Drug Delivery Systems Market Analysis
Chapter 14 Company Profiles and Key Figures in Transdermal Drug Delivery Systems Business
Chapter 15 Global Transdermal Drug Delivery Systems Market Forecast (2021-2027)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027